Nicholas Investment Partners, LP Cytokinetics Inc Transaction History
Nicholas Investment Partners, LP
- $900 Million
- Q3 2024
A detailed history of Nicholas Investment Partners, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 11,049 shares of CYTK stock, worth $516,430. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,049Holding current value
$516,430% of portfolio
0.06%Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
409Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$686 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$550 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$453 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$363 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$302 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.4B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...